Buchang Pharmaceutical (603858.SH) plans to restructure the business of Beijing Buchang and Beijing Boyuan Runbu

Zhitongcaijing · 10/18 13:33

Zhitong Finance App News, Buchang Pharmaceutical (603858.SH) issued an announcement. In order to match the company's development strategy, further optimize the company's biopharmaceutical industry layout, fully integrate the company's resources, and enhance market competitiveness, it plans to use September 30, 2024 as the reference date to restructure the company's wholly-owned subsidiary Beijing Buchang New Drug Research & Development Co., Ltd. (“Beijing Buchang”) and biopharmaceutical-related assets (other than fixed assets and scientific research equipment), business, personnel, etc. to the company's holding subsidiary, Beijing Boyuan Runbu Pharmaceutical Research and Development Co., Ltd. (“Beijing Boyuan Runbu”).